|
|
|
|
| Advertisement |
 |
|
|
| Advertisement |
Podcast: Assuring Trust in the Digital Space
Pharm Exec talks to Mollie Shields-Uehling, a leading advocate for high-assurance identity trust for cyber-transactions in the biopharmaceutical industry. Listen to the podcast for a timely, 15-minute discussion covering topics like cyber/technical security; eHealth regulatory compliance; work flow automation, the benefits of eSignature programs, and collaboration around key aspects of drug development like the administration of clinical trials and research partnering.
 Click here to listen |
|
| Advertisement |
Technology can't replace people- why Patient Support Programs need a personal approach
Live Webcast: Thursday, September 29 at 8:00 EDT
 Free registration |
|
| Advertisement |
Breaking the Circle of Distrust with a Radical PLC Pricing Model
On Demand
 Learn more |
|
| Special Feature |
 |
|
Pharm Exec's 15th Annual Industry Audit |
Our latest industry review of shareholder value reveals a sharp performance differential between companies with specialized therapeutic focus and those relying on line diversity, size and scale. By Bill Trombetta
... /Read more/ |
|
|
|
ADVERTISEMENT
|
| Advertisement |
Best Practices for Integrating Biomarkers
across the Drug Development Continuum
On Demand
 Learn more |
|
| Industry update |
| //REGENXBIO Inc. (Rockville, MD), appointed Daniel Tassé to its board of directors.//Cempra (Chapel Hill, NC) appointed John Bluth to the newly created position of Executive Vice President, Investor Relations and Corporate Communications.//MD Labs (Reno, NV) appointed Dr. Teri E. Klein of Stanford University as Chief Scientific Advisor for its Rxight Pharmacogenetics Program.// |
|
|
| |
|
